http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-287320-B6
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5305109c4efec4cbcdd8bc05bdb00399 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-00 |
| filingDate | 2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67ba19c3ee4da971b4ecfe53d9915ae4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c61e8ee3431b80bf26ec8d8ef3ff5b89 |
| publicationDate | 2010-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SK-287320-B6 |
| titleOfInvention | A process for preparing pharmaceutically acceptable salts of 2 - [(5-methoxy-1H-indol-3-yl) methylene] -N-pentylcarbazimidamide (tegaserod) |
| abstract | A method for preparing pharmaceutically acceptable salts of tegaserod from the group of tegaserod maleate, fumarate, tartrate, citrate, mesylate, lactate, succinate, oxalate, hydrochloride, salicylate, glutarate, adipate, hydrobromide, sulfate, and hydrogen sulfate salt of tegaserod, and it allows to produce a pure tegaserod salt without isolating the tegaserod base. Also described is temperature-stable crystalline tegaserod fumarate, tegaserod hydrobromide and tegaserod oxalate. |
| priorityDate | 2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.